Enrichment of Polyglucosylated Isoflavones from Soybean Isoflavone Aglycones Using Optimized Amylosucrase Transglycosylation.

Isoflavones in soybeans are well-known phytoestrogens. Soy isoflavones present in conjugated forms are converted to aglycone forms during processing and storage. Isoflavone aglycones (IFAs) of soybeans in human diets have poor solubility in water, resulting in low bioavailability and bioactivity. Enzyme-mediated glycosylation is an efficient and environmentally friendly way to modify the physicochemical properties of soy IFAs. In this study, we determined the optimal reaction conditions for Deinococcus geothermalis amylosucrase-mediated α-1,4 glycosylation of IFA-rich soybean extract to improve the bioaccessibility of IFAs. The conversion yields of soy IFAs were in decreasing order as follows: genistein > daidzein > glycitein. An enzyme quantity of 5 U and donor:acceptor ratios of 1000:1 (glycitein) and 400:1 (daidzein and genistein) resulted in high conversion yield (average 95.7%). These optimal reaction conditions for transglycosylation can be used to obtain transglycosylated IFA-rich functional ingredients from soybeans.

Fiber supplements and clinically proven health benefits: How to recognize and recommend an effective fiber therapy.

BACKGROUND: Only 5% of adults consume the recommended level of dietary fiber. Fiber supplements appear to be a convenient and concentrated source of fiber, but most do not provide the health benefits associated with dietary fiber. PURPOSE: This review will summarize the physical effects of isolated fibers in small and large intestines, which drive clinically meaningful health benefits. DATA SOURCES: A comprehensive literature review was conducted (Scopus and PubMed) without limits to year of publication (latest date included: October 31, 2016). CONCLUSIONS: The physical effects of fiber in the small intestine drive metabolic health effects (e.g., cholesterol lowering, improved glycemic control), and efficacy is a function of the viscosity of gel-forming fibers (e.g., psyllium, ß-glucan). In the large intestine, fiber can provide a laxative effect if (a) it resists fermentation to remain intact throughout the large intestine, and (b) it increases percentage of water content to soften/bulk stool (e.g., wheat bran and psyllium). IMPLICATIONS FOR PRACTICE: It is important for nurse practitioners to understand the underlying mechanisms that drive specific fiber-related health benefits, and which fiber supplements have rigorous clinical data to support a recommendation. CLINICAL PEARL: For most fiber-related beneficial effects, "Fiber needs to gel to keep your patients well."

Effects of in vitro fermentation of barley ß-glucan and sugar beet pectin using human fecal inocula on cytokine expression by dendritic cells.

SCOPE: This study simulates the fermentation process of barley ß-glucan and sugar beet pectin in the human colon and monitors the degradation products formed. Additionally, immune effects of the degradation products were investigated. METHODS AND RESULTS: Immunostimulatory activity of fermentation digesta was investigated using bone marrow derived dendritic cells (BMDCs) from toll-like receptor 2/4 (TLR2/4) knockout mice, which were unresponsive to microbe-associated molecular patterns. Cytokine responses were elicited to dietary fibers and not to the SCFA and microbiota. The fermentation digesta were analyzed for their SCFA profiles and glycan metabolites over time. During fermentation the amount of insoluble precipitating fibers increased and induced as well as soluble molecules of lower molecular mass greater amounts of cytokines in BMDCs than the parental fiber. Additionally, high amounts of cytokines can be attributed to soluble galactose-rich beet pectin molecules. CONCLUSIONS: The fermentation of the two fibers led to fiber-specific amounts of SCFA, glycosidic metabolites, and different immunomodulatory properties. BMDC from TLR2/4 knockout mice did not respond to the digest microbiota and SCFA, making it a useful approach to study temporal effects of fermentation on the immunomodulatory effects of fibers.

The effects of beta-glucan on human immune and cancer cells.

Non-prescriptional use of medicinal herbs among cancer patients is common around the world. The alleged anti-cancer effects of most herbal extracts are mainly based on studies derived from in vitro or in vivo animal experiments. The current information suggests that these herbal extracts exert their biological effect either through cytotoxic or immunomodulatory mechanisms. One of the active compounds responsible for the immune effects of herbal products is in the form of complex polysaccharides known as beta-glucans. beta-glucans are ubiquitously found in both bacterial or fungal cell walls and have been implicated in the initiation of anti-microbial immune response. Based on in vitro studies, beta-glucans act on several immune receptors including Dectin-1, complement receptor (CR3) and TLR-2/6 and trigger a group of immune cells including macrophages, neutrophils, monocytes, natural killer cells and dendritic cells. As a consequence, both innate and adaptive response can be modulated by beta-glucans and they can also enhance opsonic and non-opsonic phagocytosis. In animal studies, after oral administration, the specific backbone 1-->3 linear beta-glycosidic chain of beta-glucans cannot be digested. Most beta-glucans enter the proximal small intestine and some are captured by the macrophages. They are internalized and fragmented within the cells, then transported by the macrophages to the marrow and endothelial reticular system. The small beta-glucans fragments are eventually released by the macrophages and taken up by other immune cells leading to various immune responses. However, beta-glucans of different sizes and branching patterns may have significantly variable immune potency. Careful selection of appropriate beta-glucans is essential if we wish to investigate the effects of beta-glucans clinically. So far, no good quality clinical trial data is available on assessing the effectiveness of purified beta-glucans among cancer patients. Future effort should direct at performing well-designed clinical trials to verify the actual clinical efficacy of beta-glucans or beta-glucans containing compounds.

Post-prandial responses to cereal products enriched with barley beta-glucan.

BACKGROUND: High amounts of soluble beta-glucan in barley products may exert beneficial effects on glucose tolerance and blood lipids. OBJECTIVE: To investigate the acute postprandial response on plasma glucose, insulin and lipids after consumption of two experimental products made from barley flour enriched with beta-glucan in comparison with similar products made from whole-wheat flour. METHODS: A group of 10 healthy volunteers (5 males, age 25.4 +/- 0.5 y, BMI 22.6 +/- 0.7 Kg/m(2)) received at breakfast, in random order and in different days, portions (40g of available carbohydrate) of different cereal products or white bread consumed together with a load of 90000 UI retinol. Products were crackers and cookies made either from barley or whole-wheat flour in a 2 x 2 design, where the two factors were the cereal source of dietary fiber (DF), and the food processing. Barley products supplied 12 g DF, 50% soluble, with 3.5 g of beta-glucan per portion. Whole-wheat products supplied about 14 g of dietary fiber, mainly in the insoluble form, with negligible amount of beta-glucan. Fasting and post-prandial glucose and insulin were evaluated for 180 min after the meals; retinyl-palmitate (RP) and triacylglycerol (TAG) were evaluated hourly over 8 hours. Glycemic (GI) and Insulinemic (II) indexes of products were also assessed, using white bread as reference. RESULTS: Glucose curves were significantly different between types of food processing (p < 0.01) but not between cereal sources of DF (p = 0.07). On the contrary, the effect of fiber but not of processing was evident when glucose response was expressed as Glycemic Index (effect of DF p < 0.01, effect of processing p = 0.69). Individual GI values were 78, 81, 49 and 34 for whole-wheat crackers (WWCr), whole-wheat cookies (WWc), barley crackers (BCr) and barley cookies (Bc) respectively. Insulin curves were significantly different both between type of processing and fiber source (p < 0.001 for both effects). Again, insulin indices were different between fiber but not between processing (p < 0.5 and p = 0.174 respectively). RP and TAG daily profiles were not significantly different between the factors studied. CONCLUSIONS: Products prepared from barley flour enriched with beta-glucan exhibit favourable responses on glucose metabolism, and particularly on insulinemic responses. In general, cookies responded better to the addition of barley fiber than crackers. Our results highlight the complexity of the effect that barley fiber may exert when added to different food products in reducing postprandial metabolic responses.